Search bioRxiv⌕ Search

Biology subjects

Kurt, E.

Publications and source records attributed to Kurt, E..

5 recordsLinked to original sources

Differences in LC integrity and fMRI activations in healthy aging and MCI associated with successful memory encoding

INTRODUCTIONWe examined whether the decline of delayed episodic memory in old age and MCI is related to structural integrity of the locus coeruleus (LC). We also tested whether LC integrity was associated with encoding-related brain activity, controlling for emotional salience. METHODSParticipants (28 young adults, 28 older adults, 25 MCI) memorized emotional and neutral images during fMRI. Delayed memory was tested four hours later and compared to immediate memory. LC integrity was measured with a neuromelanin-sensitive sequence. RESULTSMCI showed overall memory decline, independent of delay or emotional valence, and reduced LC integrity compared to older adults. Across participants, LC integrity correlated with delayed memory, but did not explain performance within OA or MCI. LC integrity was associated with lower activity related to encoding success and emotional salience. Groups remembered emotional better than neutral images, though memory was greatly impaired in MCI, matching with their reduce LC integrity. DISCUSSIONLC integrity was associated with lower brain activity during encoding and emotional salience processing, no clear relationship with delayed memory performance was observed in MCI.

neuroscience↗

Enhancing Lipid Production in Yarrowia lipolytica through Continuous Fermentation and Adaptive Laboratory Evolution in Bioreactors

Yarrowia lipolytica excels in microbial lipid production, thriving across diverse conditions. Batch or fed-batch fermentation is the common practice to achieve higher lipid titer and yield, but it is also subject to lower lipid productivity. Single-stage continuous fermentation (CF) provides a great potential for significantly higher productivity, but genetic instability is often seen and challenges strain performance over the long-period CF. This study harnesses single-stage CF to not only improve lipid productivity, but also evolve high-lipid mutants from a previously engineered Y. lipolytica strain E26 via adaptive laboratory evolution (ALE) in a continuous bioreactor, guided by a predictive kinetic model. The single-stage CF was run for 1128 hours (47 days) with key process parameter adjusted in a 1-L bioreactor to produce over 150 g/L yeast biomass, exceeding the targeted 113 g/L that is predicted by the model. Compared with the fed-batch fermentation process, the single-stage CF successfully improved lipid productivity from 0.3[~]0.5 g/L/h to about 1 g/L/h while maintained the lipid yield at around 0.1 g/g. The CF sample at 1008 h was used to isolate mutants with higher lipid production after ALE in the continuous bioreactor. A mutant E26E03 was identified which demonstrated improvements in biomass, lipid content, and lipid yield by 43%, 30%, and 51%, respectively, over the original strain E26 in fed-batch fermentation. Our study indicated that using model-guided CF with ALE in a continuous bioreactor provides a great potential for significantly higher product titer, rate, and yield (TRY) in biomanufacturing.

bioengineering↗

Pupil dilation as a marker of attention/effort in aging and mild cognitive impairment

Pupil dilation (PD) can be easily measured and reflects responses to subjectively salient or cognitively demanding events. It therefore holds promise as a cognitive marker especially for individuals with mild cognitive impairment (MCI) or other neurodegenerative conditions with restricted abilities to respond in cognitive assessments. We assessed PD during two tasks, an oddball task for investigating attentional allocation and a Simon task which additionally allows for investigating cognitive effort in younger adults (YAs), older adults (OAs), and patients with MCI. PD is a useful marker for investigating attention and cognitive effort in MCI, as suggested by elevated PD to salient stimuli in particular of individuals with better attentional control in MCI patients, as well as YAs and OAs. Measurement of PD may serve as an easy-to-administer measure to assess changes in cognitive function in healthy aging and MCI.

neuroscience↗

The midbody and midbody remnant are assembly sites for RNA and active translation

The midbody (MB) is a transient structure at the spindle midzone that is required for cytokinesis, the terminal stage of cell division. Long ignored as a vestigial remnant of cytokinesis, we now know MBs are released post-abscission as extracellular vesicles called MB remnants (MBRs) and can modulate cell proliferation, fate decisions, tissue polarity, neuronal architecture, and tumorigenic behavior. Here, we demonstrate that the MB matrix--the structurally amorphous MB core of unknown composition--is the site of ribonucleoprotein assembly and is enriched in mRNAs that encode proteins involved in cell fate, oncogenesis, and pluripotency, that we are calling the MB granule. Using a quantitative transcriptomic approach, we identified a population of mRNAs enriched in mitotic MBs and confirmed their presence in signaling MBR vesicles released by abscission. The MB granule is unique in that it is translationally active, contains both small and large ribosomal subunits, and has both membrane-less and membrane-bound states. Both MBs and post-abscission MBRs are sites of spatiotemporally regulated translation, which is initiated when nascent daughter cells re-enter G1 and continues after extracellular release. We demonstrate that the MB is the assembly site of an RNP granule. MKLP1 and ARC are necessary for the localization and translation of RNA in the MB dark zone, whereas ESCRT-III was necessary to maintain translation levels in the MB. Our data suggest a model in which the MB functions as a novel RNA-based organelle with a uniquely complex life cycle. We present a model in which the assembly and transfer of RNP complexes are central to post-mitotic MBR function and suggest the MBR serves as a novel mode of RNA-based intercellular communication with a defined biogenesis that is coupled to abscission, and inherently links cell division status with signaling capacity. To our knowledge, this is the first example of an autonomous extracellular vesicle with active translation activity. HighlightsO_LIThe MB, the center region of the intercellular bridge, is the assembly site of a ribonucleoprotein granule, we call the MB granule C_LIO_LIDistinct oncogenic and pluripotent transcription factor RNAs, including Jun/Fos and KLF4, are packaged in MBs and MBRs C_LIO_LIThe MB granule is coincident with the MB matrix, or dark zone, of the MB C_LIO_LIThe Kif23/MKLP1 kinesin is a core hexanediol-sensitive MB granule component C_LIO_LIThe MB and MBR are site of active translation that begins in early G1 and continues post-mitotically C_LIO_LIMKLP1 and ARC are necessary for RNA targeting/maintenance and translation at the MB C_LIO_LIDepletion of ESCRT-III increases the levels of translation during abscission C_LIO_LIAbscission releases MBRs as MB granule-harboring, translating extracellular vesicles C_LIO_LIMultiple cell types including cancer, stem, neural stem, all have actively translating MBRs C_LIO_LIMBRs are proposed as a novel mode of intercellular communication by extracellular vesicle-mediated direct transfer of RNA C_LI

cell biology↗

Small Molecule Inhibition of the Innate Immune Response Increases Transgene Expression

Foreign molecules like plasmid DNA trigger a complex and potent innate immune response comprised of highly redundant signal transduction cascades that result in the activation of transcription factors and the production of inflammatory cytokines. Unfortunately, this defense mechanism can hinder gene therapy by inhibiting transgene expression. The goal of this study was to increase transgene expression by inhibiting key components of the innate immune response ({beta}-catenin, NF-{kappa}B/AP1, TBK1, TLR9, and p38 MAPK) with small molecule inhibitors (iCRT-14, curcumin, BX-795, E6446, and VX-702 respectively). The effects of each drug on transgene (luciferase) expression, inflammatory cytokine (IL-6) levels, and cell viability were quantified in prostate (PC3), breast (MCF-7), and murine bladder (MB49) cancer cell lines. The {beta}-catenin inhibitor iCRT-14 (1 M) provided the highest enhancement of 35.5 {+/-} 19-fold in MCF-7 cells, while the other inhibitors increased transgene expression at a more modest level (2-9 fold). The optimal concentrations of iCRT-14, curcumin, and VX-702 showed no significant effect on cell proliferation; however, optimal concentrations of BX-795 and E6446 did significantly reduce cell proliferation. Nonetheless, inhibition of the innate immune response by iCRT-14 and curcumin was confirmed by a concomitant decrease in IL-6 production in PC3 cells. These results demonstrate that these inhibitors can improve gene therapy by preventing an inflammatory innate immune response.

bioengineering↗